Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Takayuki Sumiyoshi
Observed names:
Sumiyoshi, Takayuki,
T. Sumiyoshi,
TAKAYUKI SUMIYOSHI
Institution:
Kyoto University
Observed institutions:
Kyushu University,
University of British Columbia,
Kyoto University,
Kobe Medical Center,
Kyoto University Hospital,
Osaka Red Cross Hospital,
Kobe City Medical Center General Hospital,
Vancouver Prostate Centre
show all 8
ORCID:
0000-0001-5321-6014
Observed ORCID:
0000-0001-5321-6014
OpenAlex ID:
A5068321009
Works
184
Awards
2
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
2024
·
Nicolette M. Fonseca
, Corinne Maurice-Dror
, et al.
·
Nature Communications
·
157
PDF
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
2019
·
Takayuki Sumiyoshi
, Kei Mizuno
, et al.
·
Scientific Reports
·
79
PDF
CCL 2 as a potential therapeutic target for clear cell renal cell carcinoma
2016
·
Ryuichiro Arakaki
, Toshinari Yamasaki
, et al.
·
Cancer Medicine
·
68
PDF
Association of Missense Polymorphism inHSD3B1With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone
2019
·
Masaki Shiota
, Shintaro Narita
, et al.
·
JAMA Network Open
·
67
PDF
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
2023
·
Sofie H. Tolmeijer
, Emmy Boerrigter
, et al.
·
Clinical Cancer Research
·
66
PDF
Prostate cancer and liquid biopsies: Clinical applications and challenges
2024
·
Fumihiko Urabe
, Takayuki Sumiyoshi
, et al.
·
International Journal of Urology
·
32
PDF
Antimicrobial prophylaxis to prevent perioperative infection in urological surgery: a multicenter study
2013
·
Yoshikazu Togo
, Shingo Yamamoto
, et al.
·
Journal of Infection and Chemotherapy
·
30
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)
2023
·
Jimmy L. Zhao
, Emmanuel S. Antonarakis
, et al.
·
British Journal of Cancer
·
27
PDF
Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer
2022
·
Hiroko Kimura
, Kei Mizuno
, et al.
·
British Journal of Cancer
·
25
Establishment and characterization of a novel treatment‐related neuroendocrine prostate cancer cell line KUCaP13
2021
·
Kosuke Okasho
, Kei Mizuno
, et al.
·
Cancer Science
·
24
PDF
Clinical implications of genomic alterations in metastatic prostate cancer
2021
·
Takayuki Sumiyoshi
, Kim N. Chi
, et al.
·
Prostate Cancer and Prostatic Diseases
·
21
Detection of von Hippel‐Lindau gene mutation in circulating cell‐free DNA for clear cell renal cell carcinoma
2021
·
Takayuki Sumiyoshi
, Toshinari Yamasaki
, et al.
·
Cancer Science
·
20
The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer
2021
·
Masaki Shiota
, Shusuke Akamatsu
, et al.
·
The Pharmacogenomics Journal
·
18
eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNA
2019
·
Kei Mizuno
, Shusuke Akamatsu
, et al.
·
Scientific Reports
·
18
PDF
Clinical Utility of Serial Circulating Tumor DNA Analysis as a Minimally Invasive Biomarker in Advanced Urothelial Cancer
2025
·
Toru Sakatani
, Takayuki Sumiyoshi
, et al.
·
JCO Precision Oncology
·
13
Recent advances in basic research on prostate cancer: Where we are heading?
2024
·
Daisuke Obinata
, Yasutaka Yamada
, et al.
·
International Journal of Urology
·
13
PDF
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial
2023
·
Takayuki Sumiyoshi
, Xiaofei Wang
, et al.
·
JNCI Journal of the National Cancer Institute
·
12
PDF
Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer
2019
·
Maki Fujiwara
, Shusuke Akamatsu
, et al.
·
Clinical Genitourinary Cancer
·
12
Spatial Pattern of Intraprostatic Recurrence after Definitive External-Beam Radiation Therapy for Prostate Cancer: Implications for Focal Boost to Intraprostatic Dominant Lesion
2024
·
Rihito Aizawa
, Tomoaki Otani
, et al.
·
Advances in Radiation Oncology
·
11
PDF
Impact of prostate position-based image-guidance in intensity-modulated radiation therapy for localized prostate cancer
2024
·
Rihito Aizawa
, Haruo Inokuchi
, et al.
·
International Journal of Clinical Oncology
·
10
PDF
A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity
2024
·
Hiroshi Fujiwara
, Masashi Kubota
, et al.
·
International Journal of Clinical Oncology
·
9
Extracellular vesicles secreted from bone metastatic renal cell carcinoma promote angiogenesis and endothelial gap formation in bone marrow in a time-dependent manner in a preclinical mouse model
2023
·
Masashi Takeda
, Hiromasa Sakamoto
, et al.
·
Frontiers in Oncology
·
9
PDF
Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRI
2025
·
RIHITO AIZAWA
, TAKASHI OGATA
, et al.
·
Anticancer Research
·
8
PDF
Effects of aging on complications following robot-assisted radical prostatectomy
2024
·
Shigeki Koterazawa
, Masashi Kubota
, et al.
·
International Journal of Clinical Oncology
·
8
Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
2024
·
Masashi Kubota
, Mutsushi Kawakita
, et al.
·
Scientific Reports
·
8
PDF
Show more works
View as search
Works count:
184
Citation count:
861
H-index:
14
I10-index:
20
Year
Topic
Type